Edward Gerstenfeld

Husband, father, specialist in treating Heart Rhythm Disorders, seeker of truth, Democrat for saner government, Duke fan.

[Edward Gerstenfeld @Ed_Gerst]

All- a bit tired of negativity on X and owner (who I used to have great respect for) spreading misinformation and lies. Going to switch completely to Threads. Have a great weekend.

[Edward Gerstenfeld @Ed_Gerst]

Thx for coming and contributing Jason! Great to have you.

[Jason Andrade @DrJasonAndrade]

The California Heart Rhythm Symposium is a fantastic meeting that really showcases the amazing work being done in the California heart rhythm community.

Many thanks to @Ed_Gerst @JDMossMD @shivkumarmd @gregorymmarcus Greg Feld for inviting me to participate.

[Edward Gerstenfeld @Ed_Gerst]

CHRS2024. The only meeting where a cardiac surgeon will pour you wine from his winery while learning about arrhythmias! @JDMossMD @gregorymmarcus @shivkumarmd

[Edward Gerstenfeld @Ed_Gerst]

CHRS2024. @MiguelVldrbno the expert on alcohol ablation, discussing ablation of VT from the LV summit.

[Edward Gerstenfeld @Ed_Gerst]

@SZDiederichsen @drjohnm @jeffrey_vinocur Nice study but that’s a completely different group, though. Asymptomatic AF detected by ILR with burden <1%. Very different from persistent AF which does not really go away.

[Edward Gerstenfeld @Ed_Gerst]

Anyone surprised? @drjohnm

[Edward Gerstenfeld @Ed_Gerst]

@jeffrey_vinocur @drjohnm Regression to the mean…

[Edward Gerstenfeld @Ed_Gerst]

Sign up now for the California Heart Rhythm Symposium 2024 in beautiful Sonoma CA, for discussion of the latest EP controversies.
@DrJasonAndrade @DougPacker @MiguelVldrbno @nmarrouche @shivkumarmd Jeffrey Healey, Bill Stevenson, Wendy Tzou and more!
https://t.co/YOQgItZzll

[Edward Gerstenfeld @Ed_Gerst]

We welcome @DanielPMorin to the UCSF EP family! @gregorymmarcus @Jeffolgin @JDMossMD @HHsiaMD

[UCSF Cardiology @UCSFCardiology]

Welcome @danielpmorin MD who joins #UCSFCardiology in Nov. An experienced clinician-researcher and HRS Board of Trustees member, Dan will focus on CRM device implantation/management/extraction, complex ablation, clinical/translational research, and mentorship @UCSFHospitals.

[Edward Gerstenfeld @Ed_Gerst]

Agree with Fermin of course! QRS transition is late in SR and PVC r is prominent in V1 and v2.

[Fermin Carlos Garcia @DrFerminGarcia]

@javadm20 That’s is true, ECG is a guide not an absolute. Anatomy is always the most important factor. However this pvc looks like an LVOT SOO, based on the V2 transition ratio which seems to be consistent with a PVC transitioning in V3 of left side origin. @andresenriqueza @Ed_Gerst

[Edward Gerstenfeld @Ed_Gerst]

@narrowQRS No backup??

[Edward Gerstenfeld @Ed_Gerst]

@Dr_Markman @dhakalbish @JRWinterfield @MUSC_EP @PennEPFellows @True_EP @JDMossMD Many of the truths that we cling to depend on our point of view

[Edward Gerstenfeld @Ed_Gerst]

Sign up now for the California Heart Rhythm Symposium 2024 in beautiful Sonoma CA, for discussion of the latest EP controversies.
@DrJasonAndrade @DougPacker @MiguelVldrbno @nmarrouche @shivkumarmd Jeffrey Healey, Bill Stevenson, Wendy Tzou and more!
https://t.co/YOQgItZzll

[Edward Gerstenfeld @Ed_Gerst]

Is mapping necessary when using PFA to treat AF? It definitely makes delivery of ablation lesions much more predictable and avoids narrow isthmus on posterior wall.

[Edward Gerstenfeld @Ed_Gerst]

Everything is global…. Scribe unavailable for clinic due to protests in Bangladesh….

[Edward Gerstenfeld @Ed_Gerst]

@narrowQRS Agree with @narrowQRS. I follow him and did not see this. Very disappointing. Is there another site that is better now?

[Edward Gerstenfeld @Ed_Gerst]

@VicFerrariMD Tx Vic!

[Edward Gerstenfeld @Ed_Gerst]

Ok need help on this one from any Italians. This is the tag on a new shirt. What am I not supposed to do and how do I wash it??

[Edward Gerstenfeld @Ed_Gerst]

@EduardoSaad3 @EHRAPresident @SteliosTzeis @JonKalmanEP Success and complication rates?

[Edward Gerstenfeld @Ed_Gerst]

@PriyaPBK @SteliosTzeis @EHRAPresident @JonKalmanEP @EduardoSaad3 The typical progression would be to understand the mechanism first and then design the trial. We have largely been in reverse - "learning by burning." having more mechanistic info would really drive progress faster IMHO. We have seen little new beyond PVI. #EHRAchat